Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0095 (-95.00%)
At close: Dec 26, 2025

Actavia Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Net Income
-0.41-4.44-0.69-0.88-5.35-0.94
Depreciation & Amortization
---000
Other Amortization
0.030.180.890.55--
Asset Writedown & Restructuring Costs
----4.87-
Stock-Based Compensation
-3.86-0.040.130.37
Other Operating Activities
0.030.02-0.580.120.040.02
Change in Accounts Receivable
---00.010.22
Change in Accounts Payable
0.040.11-0.01-0.120.050.17
Change in Other Net Operating Assets
0.240.260.09-0-0.010.06
Operating Cash Flow
-0.07-0.01-0.31-0.29-0.25-0.09
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Short-Term Debt Issued
-0.110.410.290.220.1
Total Debt Issued
0.10.110.410.290.220.1
Short-Term Debt Repaid
--0.07-0.07---
Total Debt Repaid
-0.03-0.07-0.07---
Net Debt Issued (Repaid)
0.070.040.340.290.220.1
Financing Cash Flow
0.070.040.340.290.220.1

Net Cash Flow

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Net Cash Flow
-00.040.03-0-0.040.01

Free Cash Flow

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Free Cash Flow
-0.07-0.01-0.31-0.29-0.25-0.09
Free Cash Flow Growth
------
Free Cash Flow Per Share
---0.00-0.00-0.00-0.00
Levered Free Cash Flow
0.011.57-0.520.03-0.190.24
Unlevered Free Cash Flow
0.011.52-0.81-0.2-0.170.26

Additional Metrics

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Change in Working Capital
0.280.370.07-0.120.050.45